Cancer Vaccines

Baylor Research Institute to Collaborate with Mount Sinai School of Medicine to Develop Therapeutic Cancer Vaccines

Published in Cancer Weekly, October 30th, 2007

Officials with Baylor Research Institute and the Mount Sinai School of Medicine announced that the institutions are collaborating to develop therapeutic cancer vaccines for patients with lymphoma and myeloma, both cancers that affect the immune system. Additionally, the researchers will investigate ways to better diagnose autoimmune disorders such as arthritis and lupus.

"The common link between these conditions is the immune system. Both of our organizations have a unique focus in immunology research so this collaboration is a natural fit," explains Michael Ramsay, M.D., President, Baylor Research Institute. "With Baylor's advanced laboratory capabilities and Mount...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Cancer Weekly

Source: Cancer Weekly (2007-10-30)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry